EBIT: Income before interest and taxes.
Tvardi Therapeutics, Inc. (TVRD) had EBIT of $-26.75M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-18.21M |
|
-- |
|
-- |
|
$26.75M |
|
$-26.75M |
|
$8.53M |
|
$-18.21M |
|
$-18.21M |
|
$-18.21M |
|
$-18.21M |
|
$-18.21M |
|
$-18.21M |
|
|
EBIT |
$-26.75M |
$-26.85M |
|
7.42M |
|
7.78M |
|
$-2.46 |
|
$-3.26 |
|
| Balance Sheet Financials | |
$31.54M |
|
$0.05M |
|
$0.54M |
|
$32.07M |
|
$11.04M |
|
-- |
|
$0.09M |
|
$11.13M |
|
$20.95M |
|
$20.62M |
|
$20.95M |
|
9.38M |
|
| Cash Flow Statement Financials | |
$-23.50M |
|
$-10.08M |
|
$22.70M |
|
$31.61M |
|
$20.73M |
|
$-10.88M |
|
$1.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.50M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-86.96% |
|
-88.31% |
|
-56.79% |
|
-86.96% |
|
$2.23 |
|
$-3.02 |
|
$-3.02 |
|